Mao, F., Li, J., Luo, Q., Wang, R., Kong, Y., Carlock, C., . . . Liu, X. (2018). Plk1 inhibition enhances the efficacy of BET epigenetic reader blockade in castration-resistant prostate cancer. Mol Cancer Ther.
Chicago-stil citatMao, Fengyi, Jie Li, Qian Luo, Ruixin Wang, Yifan Kong, Colin Carlock, Zian Liu, Bennet D. Elzey, och Xiaoqi Liu. "Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-resistant Prostate Cancer." Mol Cancer Ther 2018.
MLA-referensMao, Fengyi, et al. "Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-resistant Prostate Cancer." Mol Cancer Ther 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.